source
- Assertio accepts new buyout bid; AI biotech Isomorphic banks $2BAssertio’s latest offer represents a roughly 31% premium over an initial acquisition proposal. Elsewhere, Kyverna is readying a first-of-its-kind approval application and AC Immune is swapping CEOs.BioPharma Dive · 2mo ago↗ source
- New subpoena suggests DOJ has begun criminal investigation of gender-affirming careSeveral hospitals have received federal grand jury subpoenas regarding gender-affirming care for minors, suggesting a criminal investigation has begun.STAT · 2mo ago↗ source
- STAT+: Gene therapy viruses linked to a boy’s tumorThe case for Makary as the WOAT, Cassidy's seat at risk ahead of midterms, and other biotech news from The ReadoutSTAT · 2mo ago